In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Shire licenses European rights to ML's icodextrin products

Executive Summary

Shire Pharmaceuticals licensed exclusive European rights to ML Laboratories' Adept (icodextrin), a liquid treatment for internal scarring following abdominal surgery, and an exclusive option to sell another icodextrin product in Europe, Dexemel, an intraperitoneal drug delivery system.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
  • Pharmaceuticals
    • Specialty Pharmaceuticals
Deal Status
  • Terminated
Deal Type
  • Alliance
    • Intra-Biotech Deal
    • R+D and Marketing-Licensing

Related Companies

UsernamePublicRestriction

Register